Literature DB >> 29891448

[Role of inducible costimulatory molecule-mediated Th17 cell polarization in renal fibrosis in spontaneously hypertensive rats].

Yu Wang1, Bo-Shi Wang, Xu Hui, Jun Qiao, Wei-Zhen Li, Nan Sun.   

Abstract

OBJECTIVE: To explore the role of inducible costimulatory molecule (ICOS) signaling pathway-mediated Th17 cells polarization in renal damage in essential hypertension.
METHODS: Four-week-old spontaneously hypertensive rats (SHR) were randomly divided into control (SHR-C) group and intervention (SHR-I) group and subjected to intraperitoneal injections of PBS and ICOS monoclonal antibody for 2 weeks, respectively. Blood pressure of the rats was monitored using noninvasive tail artery blood pressure measuring instrument. The percentage of Th17 cells in the splenocytes was analyzed using flow cytometry, and the expression levels of IL-17A mRNA in the rat's kidneys were detected using RT-PCR. The levels of IL-17A and TGF-β1 in the plasma and kidneys were dynamically detected using ELISA and immunohistochemistry, respectively. Renal pathological changes in the rats were detected using Masson staining.
RESULTS: At the age of 10 and 30 weeks, the rats in SHR-C group had a significantly higher blood pressure than those in SHR-I group (P<0.05 or 0.01). In rats in SHR-C group, Th17 cells percentage in the splenocytes and IL-17A mRNA level in the kidney was significantly higher than those in SHR-I group from the age of 6 weeks (P<0.05). The expressions of IL-17A and TGF-β1 in the plasma and kidney were significantly higher in SHR-C group than that in SHR-I group at 6 weeks (P<0.05). Compared with those in SHR-C group, the rats in SHR-I group showed significant alleviation of renal fibrosis from the age of 30 weeks (P<0.05).
CONCLUSION: The ICOS signaling pathway-mediated Th17 cells polarization plays an important role in renal fibrosis in hypertensive rats.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29891448      PMCID: PMC6743898     

Source DB:  PubMed          Journal:  Nan Fang Yi Ke Da Xue Xue Bao        ISSN: 1673-4254


  28 in total

1.  Inducible costimulator (ICOS) is a marker for highly suppressive antigen-specific T cells sharing features of TH17/TH1 and regulatory T cells.

Authors:  Marc Vocanson; Aurore Rozieres; Anca Hennino; Gaelle Poyet; Vincent Gaillard; Sarah Renaudineau; Amine Achachi; Josette Benetiere; Dominique Kaiserlian; Bertrand Dubois; Jean-François Nicolas
Journal:  J Allergy Clin Immunol       Date:  2010-07-10       Impact factor: 10.793

Review 2.  The immune system and hypertension.

Authors:  Madhu V Singh; Mark W Chapleau; Sailesh C Harwani; Francois M Abboud
Journal:  Immunol Res       Date:  2014-08       Impact factor: 2.829

3.  Resveratrol attenuates hyperproliferation of vascular smooth muscle cells from spontaneously hypertensive rats: Role of ROS and ROS-mediated cell signaling.

Authors:  Sara Almajdoob; Ekhtear Hossain; Madhu B Anand-Srivastava
Journal:  Vascul Pharmacol       Date:  2017-12-19       Impact factor: 5.773

4.  T-cell co-stimulation through B7RP-1 and ICOS.

Authors:  S K Yoshinaga; J S Whoriskey; S D Khare; U Sarmiento; J Guo; T Horan; G Shih; M Zhang; M A Coccia; T Kohno; A Tafuri-Bladt; D Brankow; P Campbell; D Chang; L Chiu; T Dai; G Duncan; G S Elliott; A Hui; S M McCabe; S Scully; A Shahinian; C L Shaklee; G Van; T W Mak; G Senaldi
Journal:  Nature       Date:  1999-12-16       Impact factor: 49.962

Review 5.  Immunological Aspects of Hypertension.

Authors:  Daniela Carnevale; Giuseppe Lembo
Journal:  High Blood Press Cardiovasc Prev       Date:  2016-04-14

Review 6.  The role of interleukin-17A in the pathogenesis of kidney diseases.

Authors:  Charlotte Cortvrindt; Reinhart Speeckaert; Alena Moerman; Joris R Delanghe; Marijn M Speeckaert
Journal:  Pathology       Date:  2017-03-11       Impact factor: 5.306

Review 7.  Role of T lymphocytes in hypertension.

Authors:  Jiandong Zhang; Steven D Crowley
Journal:  Curr Opin Pharmacol       Date:  2014-12-15       Impact factor: 5.547

8.  Spironolactone decreases DOCA-salt-induced organ damage by blocking the activation of T helper 17 and the downregulation of regulatory T lymphocytes.

Authors:  Cristián A Amador; Víctor Barrientos; Juan Peña; Andrés A Herrada; Magdalena González; Solange Valdés; Loreto Carrasco; Rodrigo Alzamora; Fernando Figueroa; Alexis M Kalergis; Luis Michea
Journal:  Hypertension       Date:  2014-01-13       Impact factor: 10.190

9.  Enhanced inducible costimulator ligand (ICOS-L) expression on dendritic cells in interleukin-10 deficiency and its impact on T-cell subsets in respiratory tract infection.

Authors:  Xiaoling Gao; Lei Zhao; Shuhe Wang; Jie Yang; Xi Yang
Journal:  Mol Med       Date:  2013-11-08       Impact factor: 6.354

10.  Interleukin 17 promotes angiotensin II-induced hypertension and vascular dysfunction.

Authors:  Meena S Madhur; Heinrich E Lob; Louise A McCann; Yoichiro Iwakura; Yelena Blinder; Tomasz J Guzik; David G Harrison
Journal:  Hypertension       Date:  2009-12-28       Impact factor: 10.190

View more
  1 in total

1.  [Interleukin-17A is closely correlated with the progression of renal epithelial-mesenchymal transition in spontaneously hypertensive rats].

Authors:  M Xiang; Y Wang; R Mei; J Fu; J Chen; C DU
Journal:  Nan Fang Yi Ke Da Xue Xue Bao       Date:  2022-05-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.